APONTIS PHARMA AGAPONTIS PHARMA AGAPONTIS PHARMA AG

APONTIS PHARMA AG

No trades
See on Supercharts

APPH fundamentals

An in-depth look to APONTIS PHARMA AG operating, investing, and financing activities

APPH free cash flow for H1 24 is -3.88 M EUR. For 2023, APPH free cash flow was -12.27 M EUR and operating cash flow was -12.26 M EUR.

‪0.00‬
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: EUR
TTM
Free cash flowYoY growth